Presentation Information

[D2-A2-04]KRAS G12D IHC Assay Reveals Target Degradation by Setidegrasib in Cancer Patient Tumor Samples

*Toshiko Yahata1, Fumio Osaki1, Masayasu Yoshino1 (1. Astellas Pharma Inc.)

Password required to view


Comment

To browse or post comments, you must log in.Log in